Fibrinolysis in idiopathic menorrhagia.
Bisht, D; Gupta, S C; Kaushik, S; Ganguli, G; Mital, V P.
Indian J Pathol Microbiol
; 1991 Jul; 34(3): 200-2
Artículo
en Inglés
| IMSEAR | ID: sea-74868
Serum fibrin/fibrinogen degradation product (FDP) was studied in 64 patients of menorrhagia without any organic cause in addition to 24 healthy women by Thrombo - Wellcotest HA - 13 Kit (Wellcome, England). Serum FDP levels were found to be less than 10 micrograms/ml in healthy subjects, whereas in idiopathic menorrhagia it was more than 10 micrograms/ml in 59.34% patients. Semi-quantitative estimation of FDP in 14 patients of idiopathic menorrhagia indicated a positive correlation between duration of bleeding and FDP levels. Bleeding appears to be due to increased fibrinolytic activity in uterus secondary to plasminogen activator. Such patients are likely to be benefitted with anti-fibrinolytic agents.
Texto completo
Documentos relacionados